oxaliplatin
Showing 26 - 50 of 922
Lung Metastases, Colorectal Cancer Metastatic, Colorectal Cancer Trial (Oxaliplatin)
Not yet recruiting
- Lung Metastases
- +2 more
- Oxaliplatin
- (no location specified)
Nov 3, 2022
Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)
Recruiting
- Gastric Cancer
- SHR1210
- +3 more
-
Jinan, Shandong, ChinaQilu hospital of Shandong univertisy
Mar 30, 2022
Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)
Recruiting
- Biliary Tract Tumor
- Tislelizumab
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Mar 14, 2022
Non-hodgkin Lymphoma,B Cell, Refractory DLBCL, Relapsed DLBCL Trial in United States (MT-3724, Gemcitabine, Oxaliplatin)
Terminated
- Non-hodgkin Lymphoma,B Cell
- +2 more
- MT-3724
- +2 more
-
Orange, California
- +8 more
Jul 18, 2022
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Locally Advanced Unresectable Gastric Adenocarcinoma Trial in Tianjin (Oxaliplatin, Capecitabine, Cadonilimab)
Not yet recruiting
- Locally Advanced Unresectable Gastric Adenocarcinoma
- Oxaliplatin
- +2 more
-
Tianjin, Tianjin, ChinaXuewei Ding
Aug 2, 2023
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)
Completed
- Gastric Cancer
- GastroEsophageal Cancer
- SHR-1210
- +3 more
-
Hefei, Anhui, China
- +9 more
Jun 30, 2022
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)
Not yet recruiting
- Advanced Solid Tumor
- JS015
- +10 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 17, 2023
GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
- Neratinib
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 25, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)
Recruiting
- Colorectal Carcinoma
- Sintilimab
- +2 more
-
Guangzhou, ChinaSun Yat-sen University
Dec 29, 2022
Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)
Not yet recruiting
- Extranodal NK/T-cell Lymphoma
- Sugemalimab
- +4 more
- (no location specified)
Jan 17, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)
Not yet recruiting
- Colon Neoplasm
- Oxaliplatin
- +4 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Trifluridine/Tipiracil
- +2 more
-
Amiens, France
- +20 more
Jul 26, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022